A. Hovakimyan

发表

A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

N. Petrovsky, D. Cribbs, I. Petrushina, 2019, Scientific Reports.

Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein

E. Masliah, D. Cribbs, I. Petrushina, 2022, International journal of molecular sciences.

Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: Feasibility study

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Neuroscience Letters.

Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

E. Masliah, E. Rockenstein, D. Cribbs, 2022, npj Vaccines.

Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

N. Petrovsky, D. Cribbs, I. Petrushina, 2022, npj Vaccines.

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

D. Logunov, E. Nelson, A. Ghochikyan, 2014, Journal of Translational Medicine.

A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory

R. Albrecht, A. García-Sastre, A. Ghochikyan, 2014, Journal of Neuroimmunology.

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

E. Nelson, A. Ghochikyan, R. Ataullakhanov, 2014, Clinical & Experimental Metastasis.

Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

D. Cribbs, G. F. Passos, I. Petrushina, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Refinement of a DNA based Alzheimer disease epitope vaccine in rabbits

A. Kiyatkin, D. Cribbs, I. Petrushina, 2013, Human vaccines & immunotherapeutics.

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

N. Petrovsky, D. Cribbs, I. Petrushina, 2019, Alzheimer's Research & Therapy.

Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

N. Petrovsky, D. Cribbs, I. Petrushina, 2016, Scientific Reports.

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

N. Petrovsky, D. Cribbs, D. Morgan, 2020, Neurobiology of Disease.

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

A. Obenaus, D. Cribbs, I. Petrushina, 2020, Neurobiology of Disease.

Epitope-based DNA vaccine for Alzheimer's disease: Translational study in macaques

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial

A. Kiyatkin, L. Pedersen, D. Cribbs, 2013, The Journal of Neuroscience.

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines

L. Pedersen, D. Cribbs, I. Petrushina, 2014, Journal of Neuroimmunology.

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

D. Cribbs, I. Petrushina, M. Blurton-Jones, 2023, International journal of molecular sciences.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

E. Nelson, A. Ghochikyan, R. Ataullakhanov, 2013, Clinical & Experimental Metastasis.